Clinical trial
A Double-Blind Therapeutic Exploratory Clinical Study to Evaluate the Efficacy of Soluble Beta-1,3/1,6-Glucan Compared to Placebo on Chronic Leg Ulcers in Diabetes Patients
NCT00288392 is registered in ClinicalTrials.gov with Biotec Pharmacon ASA as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Double-Blind Therapeutic Exploratory Clinical Study to Evaluate the Efficacy of Soluble Beta-1,3/1,6-Glucan Compared to Placebo on Chronic Leg Ulcers in Diabetes Patients
- Lead sponsor
- Biotec Pharmacon ASA
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- June 30, 2005
- Completion date
- September 30, 2006
- Enrollment
- 60
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.